MichaelDFarwellMD

PubMed

• Artificial intelligence in immunotherapy PET/SPECT imaging.
  McGale, J., Trebeschi, S., Wu, A., Cutler, C., Chen, D., Farwell, M., Schwartz, L., Dercle, L.> ;European Radiology. 2024 Feb 15
• FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma.
  Thomas M Anderson, Bryan H Chang, Alexander C Huang, Xiaowei Xu, Daniel Yoon, Catherine G Shang, Rosemarie Mick, Erin Schubert, Suzanne McGettigan, Kristin Kreider, We...> ;Clinical Cancer Research. 2024 Jan 24
• 68 Ga-DOTATATE PET to Characterize Lesions in the Neuroaxis.
  Hartmann, K., Gillman, J., Weeks, J., Lazor, J., Ware, J., Nasrallah, I., Farwell, M., Pantel, A.> ;Clinical Nuclear Medicine. 2024 Jan 1
• 2 citations
  Imaging With PET/CT of Diffuse CD8 T-Cell Infiltration of Skeletal Muscle in Patients With Inclusion Body Myositis.
  Colin Quinn, Kelsey Moulton, Michael Farwell, William Le, Ian Wilson, Niti Goel, Jonathan McConathy, Steven A Greenberg> ;Neurology. 2023 Sep 12
• 4 citations
  Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop.
  Shankar, L., Schöder, H., Sharon, E., Wolchok, J., Knopp, M., Wahl, R., Ellingson, B., Hall, N., Yaffe, M., Towbin, A., Farwell, M., Pryma, D., Poussaint, T., Wright, ...> ;The Lancet. Oncology. 2023 Mar 1
• Perfusion-only imaging in pregnant women: A comparative reader study with implications for practice patterns.
  Jennifer A Schroeder, Quy Cao, Vlasios S Sotirchos, Jennifer A Gillman, Thomas Anderson, Stamatoula Pilati, Jacob G Dubroff, Michael Farwell, Andrew Kozlov, Katrina Ko...> ;Medicine. 2022 Sep 30
• 18 citations
  Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy.
  Laurent Dercle, Jeremy McGale, Shawn Sun, Aurelien Marabelle, Randy Yeh, Eric Deutsch, Fatima-Zohra Mokrane, Michael Farwell, Samy Ammari, Heiko Schoder, Binsheng Zhao...> ;Journal for Immunotherapy of Cancer. 2022 Sep 1
• 6 citations
  Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74.
  Iris K Lee, Estela Noguera-Ortega, Zebin Xiao, Leslie Todd, John Scholler, Decheng Song, Maria Liousia, Katheryn Lohith, Kexiang Xu, Kimberly J Edwards, Michael D Farw...> ;Clinical Cancer Research. 2022 Dec 15
• 9 citations
  Using CD69 PET Imaging to Monitor Immunotherapy-Induced Immune Activation.
  Kimberly J Edwards, Bryan Chang, Hasan Babazada, Katheryn Lohith, Daniel H Park, Michael D Farwell, Mark A Sellmyer> ;Cancer Immunology Research. 2022 Sep 1
• 143 citations
  PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.
  Vivek Narayan, Julie S Barber-Rotenberg, In-Young Jung, Simon F Lacey, Andrew J Rech, Megan M Davis, Wei-Ting Hwang, Priti Lal, Erica L Carpenter, Shannon L Maude, Gab...> ;Nature Medicine. 2022 Apr 1
• 4 citations
  Analysis of Routine Computed Tomographic Scans With Radiomics and Machine Learning: One Step Closer to Clinical Practice.
  Michael D Farwell, David A Mankoff> ;JAMA Oncology. 2022 Mar 1
• 2 citations
  Immune PET Imaging.
  Osigbemhe Iyalomhe, Michael D. Farwell> ;Radiologic Clinics of North America. 2021 Sep 1
• 55 citations
  CD8-targeted PET Imaging of Tumor Infiltrating T cells in Patients with Cancer: A Phase I First-in-Human Study of 89Zr-Df-IAB22M2C, a Radiolabeled anti-CD8 Minibody.
  Michael D. Farwell, Raymond F Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian D. Wilson, Michael S. Gord...> ;Journal of Nuclear Medicine. 2021 Aug 19
• 5 citations
  18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma
  Andrew Ruff, Hatcher J. Ballard, Austin R. Pantel, Esin C. Namoglu, Mitchell E. Hughes, Sunita D. Nasta, Elise A. Chong, Adam Bagg, Marco Ruella, Michael D. Farwell, J...> ;Molecular Imaging and Biology. 2021 Jul 6
• 13 citations
  In vivo visualization of PARP inhibitor pharmacodynamics
  Elizabeth S. McDonald, Austin R. Pantel, Payal D. Shah, Michael D. Farwell, Amy S. Clark, Robert K. Doot, Daniel A. Pryma, Sean Carlin> ;JCI Insight. 2021 Apr 22
• 9 citations
  Kinetic and static analysis of poly-(adenosine diphosphate-ribose) polymerase-1 (PARP-1) targeted 18F-FluorThanatrace (18F-FTT) PET images of ovarian cancer.
  Anthony J. Young, Austin R. Pantel, Varsha Viswanath, Tiffany Dominguez, Mehran Makvandi, Hsiaoju Lee, Shihong Li, Erin K. Schubert, Daniel A. Pryma, Michael D. Farwel...> ;Journal of Nuclear Medicine. 2021 Apr 1
• 8 citations
  18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiati...
  Abhishek A. Solanki, Bital Savir-Baruch, Stanley L. Liauw, Jeff M. Michalski, Jonathan D. Tward, Neha Vapiwala, Eugene J. Teoh, Lee P. Adler, Gerald L. Andriole, Laure...> ;Practical Radiation Oncology. 2020 Sep 1
• 21 citations
  Positron Emission Tomography Imaging of Poly-(Adenosine Diphosphate-Ribose) Polymerase 1 Expression in Breast Cancer: A Nonrandomized Clinical Trial.
  Elizabeth S. McDonald, Robert K. Doot, Austin R. Pantel, Michael D. Farwell, Robert H. Mach, Kara N. Maxwell, David A. Mankoff> ;JAMA Oncology. 2020 Jun 1
• 17 citations
  Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status.
  Elizabeth S. McDonald, Robert K. Doot, Anthony J. Young, Erin K. Schubert, Julia Tchou, Daniel A. Pryma, Michael D. Farwell, Anupma Nayak, Amy Ziober, Michael Feldman,...> ;Journal of Nuclear Medicine. 2020 May 1
• 54 citations
  Imaging CAR T Cell Trafficking with eDHFR as a PET Reporter Gene.
  Mark A. Sellmyer, Sarah A. Richman, Katheryn Lohith, Catherine Hou, Chi-Chang Weng, Robert H. Mach, Roddy S. O’Connor, Michael C. Milone, Michael D. Farwell> ;Molecular Therapy. 2020 Jan 8
• 125 citations
  Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
  Rodabe N. Amaria, Alexander M. Menzies, Elizabeth M. Burton, Richard A. Scolyer, Michael T. Tetzlaff, Robert Antdbacka, Charlotte E. Ariyan, Roland L. Bassett, Brett W...> ;The Lancet. Oncology. 2019 Jul 1
• Prevalence and quantitative analysis of indium-111 pentetreotide (Octreoscan) uptake in the pancreatic head on SPECT/CT imaging: establishing a region of interest-base...
  Jamal J. Derakhshan, Michael D. Farwell> ;Nuclear Medicine Communications. 2019 Jul 1
• 405 citations
  A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
  Alexander C. Huang, Robert J. Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M. George, Patrick Yan, Sasikanth Manne, Adam A. Kraya, Bradley Wubbenhorst, Liza Dorfman,...> ;Nature Medicine. 2019 Feb 25
• 42 citations
  Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas.
  Nirav N. Shah, Sarah J. Nagle, Drew A. Torigian, Michael D. Farwell, Wei-Ting Hwang, Noelle V. Frey, Sunita D. Nasta, Daniel J. Landsburg, Anthony R. Mato, Carl H. Jun...> ;Cytotherapy. 2018 Dec 1
• 3 citations
  Incidental Orbital Neuroendocrine Metastases on 111In-OctreoScan and MRI.
  Yin Jie Chen, Michael D. Farwell> ;Clinical Nuclear Medicine. 2018 Nov 1
• Join now to see all